Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Splenectomy | 3 | 2025 | 62 | 1.790 |
Why?
|
| Vascular Malformations | 3 | 2025 | 111 | 1.630 |
Why?
|
| Internship and Residency | 9 | 2023 | 1252 | 1.530 |
Why?
|
| Lymphatic Abnormalities | 5 | 2024 | 36 | 1.400 |
Why?
|
| Surgeons | 4 | 2023 | 284 | 1.350 |
Why?
|
| Hemangioma | 6 | 2025 | 97 | 1.340 |
Why?
|
| Spleen | 2 | 2025 | 275 | 1.290 |
Why?
|
| Anorectal Malformations | 2 | 2025 | 15 | 1.130 |
Why?
|
| Burnout, Professional | 5 | 2021 | 133 | 1.120 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 564 | 1.020 |
Why?
|
| Splenic Vein | 1 | 2025 | 11 | 0.920 |
Why?
|
| Splenic Artery | 1 | 2025 | 22 | 0.920 |
Why?
|
| Sirolimus | 3 | 2024 | 241 | 0.900 |
Why?
|
| Biliary Dyskinesia | 1 | 2024 | 5 | 0.890 |
Why?
|
| Cholecystectomy | 1 | 2024 | 63 | 0.860 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 54 | 0.790 |
Why?
|
| Hirschsprung Disease | 4 | 2024 | 38 | 0.730 |
Why?
|
| Infant | 24 | 2025 | 13192 | 0.660 |
Why?
|
| Colectomy | 3 | 2024 | 84 | 0.640 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 217 | 0.630 |
Why?
|
| Registries | 4 | 2025 | 1585 | 0.610 |
Why?
|
| Postoperative Complications | 8 | 2024 | 3139 | 0.610 |
Why?
|
| Child | 31 | 2025 | 25823 | 0.600 |
Why?
|
| Ovarian Cysts | 1 | 2019 | 23 | 0.600 |
Why?
|
| Sclerotherapy | 4 | 2024 | 39 | 0.570 |
Why?
|
| Leadership | 1 | 2020 | 246 | 0.570 |
Why?
|
| Ileostomy | 1 | 2018 | 32 | 0.550 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 1394 | 0.550 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 233 | 0.530 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 27 | 0.510 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 36 | 0.510 |
Why?
|
| Embolization, Therapeutic | 2 | 2016 | 225 | 0.500 |
Why?
|
| Infant, Newborn | 17 | 2025 | 8566 | 0.500 |
Why?
|
| Humans | 59 | 2025 | 132334 | 0.500 |
Why?
|
| Retrospective Studies | 22 | 2025 | 17363 | 0.480 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 17 | 0.470 |
Why?
|
| Leukemia, Myeloid | 1 | 2014 | 81 | 0.440 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 453 | 0.430 |
Why?
|
| Treatment Outcome | 14 | 2025 | 13016 | 0.420 |
Why?
|
| Evidence-Based Medicine | 4 | 2025 | 672 | 0.420 |
Why?
|
| Nephrectomy | 1 | 2015 | 180 | 0.420 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 127 | 0.410 |
Why?
|
| Myeloproliferative Disorders | 1 | 2014 | 91 | 0.410 |
Why?
|
| Neonatal Screening | 1 | 2015 | 192 | 0.410 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 246 | 0.390 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1076 | 0.390 |
Why?
|
| Adolescent | 15 | 2025 | 20552 | 0.370 |
Why?
|
| Fecal Incontinence | 2 | 2025 | 78 | 0.370 |
Why?
|
| Constipation | 2 | 2025 | 128 | 0.360 |
Why?
|
| Child, Preschool | 14 | 2025 | 14851 | 0.360 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 36 | 0.350 |
Why?
|
| Female | 30 | 2025 | 70786 | 0.340 |
Why?
|
| General Surgery | 1 | 2013 | 216 | 0.340 |
Why?
|
| Databases, Factual | 6 | 2016 | 1230 | 0.320 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 323 | 0.310 |
Why?
|
| Algorithms | 3 | 2025 | 1720 | 0.290 |
Why?
|
| Male | 28 | 2025 | 65052 | 0.290 |
Why?
|
| Risk Assessment | 2 | 2015 | 3710 | 0.290 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 897 | 0.280 |
Why?
|
| Anus, Imperforate | 2 | 2024 | 20 | 0.270 |
Why?
|
| Survival Rate | 4 | 2015 | 2187 | 0.260 |
Why?
|
| Abnormalities, Multiple | 3 | 2024 | 983 | 0.250 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 1010 | 0.250 |
Why?
|
| Thoracic Duct | 2 | 2016 | 5 | 0.240 |
Why?
|
| Lymphography | 2 | 2016 | 13 | 0.240 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 3980 | 0.230 |
Why?
|
| Splenic Diseases | 1 | 2025 | 31 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 728 | 0.230 |
Why?
|
| United States | 8 | 2021 | 11627 | 0.220 |
Why?
|
| Urinary Incontinence | 1 | 2025 | 79 | 0.220 |
Why?
|
| Gastroschisis | 1 | 2024 | 56 | 0.210 |
Why?
|
| Job Satisfaction | 2 | 2021 | 99 | 0.200 |
Why?
|
| Personal Satisfaction | 2 | 2021 | 105 | 0.200 |
Why?
|
| Ultrasonography | 2 | 2019 | 988 | 0.200 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2024 | 88 | 0.200 |
Why?
|
| Colostomy | 1 | 2022 | 28 | 0.200 |
Why?
|
| Delphi Technique | 1 | 2024 | 240 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 1367 | 0.190 |
Why?
|
| Enterocolitis | 1 | 2023 | 29 | 0.190 |
Why?
|
| Reoperation | 2 | 2016 | 853 | 0.190 |
Why?
|
| Accreditation | 2 | 2013 | 94 | 0.190 |
Why?
|
| Pneumothorax | 1 | 2023 | 83 | 0.190 |
Why?
|
| Foreign Bodies | 2 | 2020 | 110 | 0.180 |
Why?
|
| Incidence | 3 | 2024 | 3361 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 186 | 0.180 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 781 | 0.180 |
Why?
|
| Compassion Fatigue | 1 | 2021 | 10 | 0.170 |
Why?
|
| Neuroblastoma | 2 | 2017 | 550 | 0.170 |
Why?
|
| Appendicitis | 1 | 2022 | 133 | 0.170 |
Why?
|
| Consensus | 1 | 2024 | 656 | 0.170 |
Why?
|
| Magnets | 1 | 2020 | 23 | 0.170 |
Why?
|
| Hospitals | 1 | 2023 | 436 | 0.170 |
Why?
|
| Lymphangioma | 1 | 2020 | 24 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 36 | 0.170 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 248 | 0.160 |
Why?
|
| Down Syndrome | 1 | 2023 | 230 | 0.160 |
Why?
|
| Parental Leave | 1 | 2019 | 4 | 0.160 |
Why?
|
| Harassment, Non-Sexual | 1 | 2019 | 1 | 0.160 |
Why?
|
| Incivility | 1 | 2019 | 2 | 0.160 |
Why?
|
| Prejudice | 1 | 2019 | 38 | 0.150 |
Why?
|
| Medical Errors | 2 | 2021 | 161 | 0.150 |
Why?
|
| Career Choice | 1 | 2020 | 161 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2019 | 42 | 0.150 |
Why?
|
| Gestational Age | 3 | 2024 | 1228 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 327 | 0.150 |
Why?
|
| Organizational Culture | 1 | 2019 | 104 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 96 | 0.140 |
Why?
|
| Injury Severity Score | 2 | 2016 | 229 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 186 | 0.140 |
Why?
|
| Ontario | 1 | 2018 | 90 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1126 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3742 | 0.130 |
Why?
|
| Pregnancy | 4 | 2024 | 7567 | 0.130 |
Why?
|
| Quality of Life | 2 | 2025 | 2151 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5405 | 0.130 |
Why?
|
| Shorthand | 1 | 2016 | 1 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Aggression | 1 | 2019 | 230 | 0.130 |
Why?
|
| Vascular Access Devices | 1 | 2017 | 37 | 0.130 |
Why?
|
| Surgical Stomas | 1 | 2016 | 11 | 0.130 |
Why?
|
| Aircraft | 1 | 2016 | 22 | 0.130 |
Why?
|
| Air Ambulances | 1 | 2016 | 24 | 0.130 |
Why?
|
| Patient Acuity | 1 | 2016 | 67 | 0.130 |
Why?
|
| Patient Handoff | 1 | 2016 | 24 | 0.130 |
Why?
|
| Chylothorax | 1 | 2016 | 28 | 0.130 |
Why?
|
| Age of Onset | 1 | 2018 | 626 | 0.120 |
Why?
|
| Workplace | 1 | 2017 | 82 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2017 | 118 | 0.120 |
Why?
|
| Wounds, Penetrating | 1 | 2016 | 142 | 0.120 |
Why?
|
| Mentoring | 1 | 2017 | 83 | 0.120 |
Why?
|
| Abbreviated Injury Scale | 1 | 2015 | 9 | 0.120 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 10 | 0.120 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 22 | 0.120 |
Why?
|
| Mentors | 1 | 2017 | 164 | 0.120 |
Why?
|
| Head Protective Devices | 1 | 2015 | 22 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2017 | 152 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2013 | 1071 | 0.120 |
Why?
|
| Device Removal | 1 | 2017 | 225 | 0.120 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 156 | 0.120 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 8 | 0.120 |
Why?
|
| Bicycling | 1 | 2015 | 36 | 0.120 |
Why?
|
| Hypoalbuminemia | 1 | 2014 | 16 | 0.110 |
Why?
|
| Adrenalectomy | 1 | 2015 | 40 | 0.110 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 199 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1443 | 0.110 |
Why?
|
| Risk Factors | 4 | 2024 | 10910 | 0.110 |
Why?
|
| Massachusetts | 1 | 2014 | 129 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 207 | 0.110 |
Why?
|
| Safety | 1 | 2015 | 217 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 222 | 0.110 |
Why?
|
| Time Factors | 3 | 2024 | 6455 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2014 | 249 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 78 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2015 | 144 | 0.110 |
Why?
|
| Bleomycin | 1 | 2014 | 114 | 0.110 |
Why?
|
| Physicians | 2 | 2017 | 635 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 110 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 128 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1331 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2015 | 295 | 0.100 |
Why?
|
| Gadolinium | 1 | 2014 | 116 | 0.100 |
Why?
|
| Ampulla of Vater | 1 | 2013 | 17 | 0.100 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2013 | 10 | 0.100 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 154 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 343 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2024 | 128 | 0.100 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2013 | 23 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 2303 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 380 | 0.100 |
Why?
|
| Medicaid | 1 | 2015 | 247 | 0.100 |
Why?
|
| Cloaca | 2 | 2024 | 15 | 0.100 |
Why?
|
| Adult | 7 | 2024 | 31618 | 0.100 |
Why?
|
| Body Weight | 1 | 2016 | 1005 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2556 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1305 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2015 | 251 | 0.090 |
Why?
|
| Urogenital Abnormalities | 2 | 2024 | 167 | 0.090 |
Why?
|
| SELEX Aptamer Technique | 1 | 2011 | 6 | 0.090 |
Why?
|
| Syndrome | 2 | 2024 | 1171 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 271 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2012 | 110 | 0.090 |
Why?
|
| Aged | 5 | 2016 | 21379 | 0.090 |
Why?
|
| Schools, Medical | 1 | 2012 | 123 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 281 | 0.090 |
Why?
|
| Anemia | 1 | 2014 | 351 | 0.080 |
Why?
|
| Spinal Dysraphism | 1 | 2014 | 274 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2013 | 329 | 0.080 |
Why?
|
| Contrast Media | 1 | 2014 | 508 | 0.080 |
Why?
|
| Comorbidity | 1 | 2015 | 1605 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1484 | 0.080 |
Why?
|
| Middle Aged | 5 | 2016 | 28888 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1161 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 402 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2169 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3087 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2024 | 1297 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 5150 | 0.060 |
Why?
|
| Lumbosacral Region | 1 | 2024 | 25 | 0.050 |
Why?
|
| Anal Canal | 1 | 2024 | 82 | 0.050 |
Why?
|
| Rectum | 1 | 2024 | 114 | 0.050 |
Why?
|
| Hernia, Umbilical | 1 | 2024 | 43 | 0.050 |
Why?
|
| Neck | 1 | 2024 | 142 | 0.050 |
Why?
|
| Spine | 1 | 2024 | 146 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2023 | 37 | 0.050 |
Why?
|
| Biological Factors | 1 | 2023 | 27 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2023 | 56 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2023 | 698 | 0.050 |
Why?
|
| Public Opinion | 1 | 2023 | 62 | 0.050 |
Why?
|
| Scoliosis | 1 | 2024 | 143 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2024 | 192 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2023 | 111 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2024 | 311 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 311 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2023 | 115 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2024 | 260 | 0.040 |
Why?
|
| Mutation | 1 | 2015 | 6248 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 19 | 0.040 |
Why?
|
| Empathy | 1 | 2021 | 64 | 0.040 |
Why?
|
| Pelvic Floor | 1 | 2020 | 39 | 0.040 |
Why?
|
| Appendectomy | 1 | 2020 | 89 | 0.040 |
Why?
|
| Patient Safety | 2 | 2016 | 437 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 97 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2024 | 607 | 0.040 |
Why?
|
| Adoption | 1 | 2019 | 18 | 0.040 |
Why?
|
| Program Development | 1 | 2020 | 187 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 1458 | 0.040 |
Why?
|
| Intestinal Volvulus | 1 | 2019 | 40 | 0.040 |
Why?
|
| Digestive System Abnormalities | 1 | 2019 | 39 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 61 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3853 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 389 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 333 | 0.040 |
Why?
|
| Colon | 1 | 2021 | 371 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2019 | 240 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 780 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 524 | 0.030 |
Why?
|
| Lymphangiectasis | 1 | 2016 | 2 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 455 | 0.030 |
Why?
|
| Bronchitis | 1 | 2016 | 33 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3022 | 0.030 |
Why?
|
| Punctures | 1 | 2016 | 62 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2016 | 56 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 193 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 307 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 131 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 148 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 19 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 611 | 0.030 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 32 | 0.030 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2015 | 35 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 42 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 354 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 166 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 109 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 85 | 0.030 |
Why?
|
| Cholestasis | 1 | 2016 | 157 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1188 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 287 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 259 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4545 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1964 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 213 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 153 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 663 | 0.030 |
Why?
|
| Learning | 1 | 2017 | 370 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 826 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 300 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 151 | 0.020 |
Why?
|
| Risk | 1 | 2015 | 763 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 725 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 402 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2016 | 409 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 66 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6540 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1256 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1227 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1556 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 865 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1451 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 615 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 150 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 722 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 152 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 1197 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1840 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 634 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3421 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 947 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1454 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2931 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 9945 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3619 | 0.020 |
Why?
|
| Communication | 1 | 2012 | 540 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1347 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1192 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 5009 | 0.020 |
Why?
|
| Animals | 2 | 2014 | 34989 | 0.010 |
Why?
|